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Abstract
Polyubiquitin chains are regulatory signals for a wide array of biological processes. Recent structural
studies reveal novel modes of polyubiquitin chain recognition and implicate the diverse repertoire of
interactions in providing the specificity of polyubiquitin recognition.
Introduction and context
As the name implies, ubiquitin (residues 1-76) is a
ubiquitous signaling molecule for a wide array of
biological processes, including protein degradation,
assembly of signaling complexes, and DNA damage
repair. When attached to proteins, ubiquitin or poly-
ubiquitin chains act as ‘codes’ to direct suitable protein-
protein interactions to effect or regulate specific cellular
functions. Ubiquitin is conjugated to target proteins or
itself through an isopeptide linkage between the side
chain amino group of lysine (Lys) residues and the
C-terminal carboxyl group of ubiquitin. This process is
achieved by the sequential action of ubiquitin-activating
enzymes (E1), ubiquitin-conjugating enzymes (E2), and
ubiquitin ligases (E3). The ubiquitin ‘codes’ on cellular
proteins can be monoubiquitin, multiple monoubiqui-
tins, or polyubiquitin chains of diverse length and
linkage. There are seven Lys residues on ubiquitins
(Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63),
allowing for seven possible homotypic linkages and
multiple possible mixed chains. The best characterized
polyubiquitin linkage types are those mediated by Lys48
and Lys63, with the former known in targeting proteins
for proteasomal degradation and the latter involved in
multiple signaling processes, in particular nuclear factor-
kappa-B (NF-kB) activation. Recent studies identified a
new linkage type of polyubiquitin chains: the linear
linkage formed between the N-terminal amino group
and the C-terminal carboxyl group (see ‘Interactions of
NEMO with diubiquitins: both revelations and confu-
sions’ section below). Like phosphorylation,
ubiquitination is highly reversible through the action
of deubiquitinating enzymes (DUBs) and therefore acts
as a transient and versatile signaling element.
Ubiquitin recognition by the collective entity of ubiqui-
tin-binding domains (UBDs) is at the center of ubiqui-
tin-mediated signaling. So far, investigators have
discovered over 20 types of UBDs, such as ubiquitin-
associated domains (UBAs), ubiquitin-interacting motifs
(UIMs), zinc fingers (ZFs), and Jab1/MPN domains for
the metalloprotease class of DUBs. Monoubiquitin
recognition has been extensively studied and reviewed
elsewhere [1,2], however, only limited examples of
polyubiquitin recognition were known until very
recently. Here, we will summarize recent advances in
understanding the molecular basis of diubiquitin recog-
nition and, in some cases, the extrapolation to longer
polyubiquitin chains.
Major recent advances
A very first example of diubiquitin recognition is
provided by the nuclear magnetic resonance (NMR)-
derived structure of Lys48-linked diubiquitin in complex
with a UBA domain of hHR23A, a protein implicated in
the modulation of polyubiquitin interaction with the
proteasome [3]. In this structure, the distal and the
proximal ubiquitin molecules use the conserved hydro-
phobic patch centered on residue Ile44 to grip onto
either side of the UBA domain, which consists of a
compact triple-helical bundle (Figure 1A). In a diubi-
quitin, the distal ubiquitin provides the C-terminal tail
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All distal and proximal ubiquitins are shown in green and cyan, respectively. The UBDs are shown in magenta. The Lys48 and Lys63 side chains at the linkages
are shown as stick models and are labeled. Linear linkage is shown as a continuous polypeptide and is labeled. (A) The hHR23A-Lys48 diubiquitin complex.
(B) The NEMO-linear diubiquitin complex. (C) The NEMO-Lys63 diubiquitin complex. Two-unit cell contents are shown to illustrate the interaction at the
distal ubiquitin with one NEMO molecule and the interaction at the proximal ubiquitin with another NEMO molecule. (D) The RAP80-Lys63 diubiquitin
complex. (E) The S5a-Lys48 diubiquitin complex. (F) The Rpn13-Lys48 diubiquitin complex. (G) The AMSH-LP-Lys63 diubiquitin complex. (H) The TAB2-
Lys63 diubiquitin complex. (I) An antibody Fab fragment-Lys63 diubiquitin complex. Lys, lysine; Ub, ubiquitin.
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for the isopeptide bond. The past year or so has seen an
explosion of structural information on the recognition of
Lys63-linked or Lys48-linked or linear diubiquitins. The
new structures of UBD-diubiquitin complexes from
different cellular processes provide an expanded view
of the diversity of such interactions.
Interactions of NEMO with diubiquitins:
both revelations and confusions
NEMO is the regulatory subunit of the IKK (IkB kinase)
complex for NF-kB activation. Recent studies have shown
that the UBAN (ubiquitin binding in ABIN [A20-binding
inhibitor of NF-kB activation] and NEMO [NF-kB
essential modulator]) domain directly interacts with
linear polyubiquitin chains [4-7]. The UBAN motif of
NEMO forms a dimeric coiled coil and uses both chains
for linear diubiquitin interactions. Structure-based muta-
genesis and NMR studies revealed that the Ile44 patch
and the C-terminal tail of the distal ubiquitin in linear
diubiquitin are most critical for UBAN interaction [6].
The crystal structure of the UBAN-linear diubiquitin
complex revealed interfaces that are similar to the NMR-
based studies [7]. However, despite the measured
stoichiometry in solution of one UBAN dimer per linear
diubiquitin [6,8], the crystal structure showed that two
dibubiquitin molecules interact symmetrically on each
side of the UBAN dimer [7] (Figure 1B). It is possible that
only one side of the dimeric UBAN is bound with
diubiquitin in solution and that the other side was forced
to interact with another diubiquitin molecule under the
crystallization condition. Consistent with this assess-
ment, it appears that at high diubiquitin concentrations,
there is a second, weaker binding site [8].
The UBAN motif of NEMO also directly interacts with
Lys63-linked polyubiquitin [4-6,9], albeit at a much
lower affinity than with linear diubiquitin [6]. Similar
mutagenesis and NMR-based methods revealed that the
Ile44 patch of the proximal ubiquitin in Lys63-linked
diubiquitin and the C-terminal tail of the distal
ubiquitin provide the critical binding energy for the
UBAN interaction [6]. In addition, the stoichiometry of
the interaction was shown to be one UBAN dimer per
Lys63-linked diubiquitin [6]. In contrast to the crystal
structure of the UBAN-linear diubiquitin complex [7],
the crystal structure of the UBAN-Lys63-linked diubiqui-
tin complex showed that the diubiquitin interacts with
only one side of the UBAN dimer [9] (Figure 1C). In fact,
only one ubiquitin molecule in the diubiquitin, either
the proximal or the distal ubiquitin, interacts with UBAN
in the crystal lattice, and this is different from the higher
energetic role of the proximal ubiquitin shown by
mutagenesis experiments in solution [6].
Recent NMR and cellular studies showed that the
C-terminal ZF of NEMO is also a functional UBD and
plays critical roles in NF-kB activation [10]. Remarkably,
while neither the UBAN nor the ZF domains shows any
preference for K63-linked polyubiquitin chains, they
together form a bipartite high-affinity K63-specific UBD
[11]. Further structural studies are required to reveal the
molecular basis for this specificity.
Recognition of Lys63-linked diubiquitin by UIMs of RAP80
Receptor-associated protein 80 (RAP80) plays a key role
in recruiting the Abraxas-BRCC36-BRCA1-BARD1 com-
plex to DNA damage foci for DNA repair by possessing
an Abraxas-interacting region. It also contains tandem
UIMs, which are single-helical motifs, for interaction
with Lys63-linked polyubiquitin. The crystal structure of
the tandem UIMs of RAP80 in complex Lys63-linked
diubiquitin revealed that the two UIMs of RAP80 and the
inter-UIM region form a continuous helix [12,13]. The
proximal and the distal ubiquitins of the Lys63-linked
diubiquitin interact with UIM1 and UIM2, respectively,
in a manner that involves the Ile44 patches (Figure 1D).
The specific spacing between the UIMs appears to be
critical in the specificity of the interaction for Lys63
linkage, although no direct interaction is present
between RAP80 and the Lys63-isopeptide bond [12,13].
Concerted polyubiquitin interactions
by ubiquitin receptors in the proteasome
Lys48-linked polyubiquitin recognitions by the two
ubiquitin receptors in the proteasome, S5a and Rpn13,
have been revealed by elegant crystallographic and NMR
studies [14,15]. S5a contains two independent UIMs and
its UIM2 preferentially interacts with the proximal
ubiquitin in a Lys48-linked diubiquitin (Figure 1E).
Rpn13 contains a pleckstrin-like receptor for ubiquitin
(Pru) domain and uses loops rather than secondary
structural elements for ubiquitin interaction [14]. Dibu-
qiutin recognition by Rpn13 is mediated mostly by
binding to the proximal ubiquitin at the Ile44 patch and
to the Lys48 linkage between the proximal and the distal
ubiquitin (Figure 1F). It is proposed that in the intact
proteasome, Rpn13 and S5a interact simultaneously
with tetraubiquitin or a longer polyubiquitin to accom-
plish polyubiquitin targeting to the proteasome [15].
Specificity for different linkages in DUBs
AMSH-like protease (AMSH-LP) is a Jab1/MPN domain-
containingDUBwithaZn-coordinatingcatalyticcore.The
crystal structure of Lys63-linked diubiquitin in complex
with AMSH-LP revealed that the distal ubiquitin uses the
Ile44 hydrophobic patch for interaction with AMSH-LP
while the proximal ubiquitin uses an alternative surface
[16]. Most strikingly, the surface of AMSH-LP forms a
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of the proximal ubiquitin and the isopeptide-linked
C-terminal tail of the distal ubiquitin (Figure 1G). Only
the Lys63-linked proximal ubiquitin can bind in the
proper orientation for catalysis. Sequence similarity also
suggests that the specificity of AMSH for Lys63-linked
chains is derived primarily from the interactions with the
proximal ubiquitin. Bidentate recognition of both prox-
imal and distal ubiquitins has also been shown as the
mechanism of specificity for K48 linkage in the ovarian
tumor domain-containing DUB, Otubain 1 [17].
Specific recognition of Lys63-linked diubiquitin
conformation by TAB2 and TAB3
Activation of the kinase TAK1 in JNK and NF-kB
signaling pathways requires interaction with Lys63-
linked polyubiquitin chains by the TAK1-binding
proteins, TAB2 and TAB3. TAB2 and TAB3 recognize
Lys63-linked chains, but not linear chains, using their
C-terminal Np14 zinc finger (NZF) domains. Crystal
structures of the TAB2 NZF domain in complex with
Lys63-linked diubiquitin or triubiquitin and the TAB3
NZF domain in complex with Lys63-linked diubiquitin
reveal that each NZF domain interacts with a diubiquitin
using two distinct binding sites and that multiple NZF
domains could recognize longer polyubiquitin chains
successively [18,19] (Figure 1H). The NZF domains
recognize the Ile44 hydrophobic patches of both the
proximal and the distal ubiquitins in a diubiquitin.
Interestingly, the Lys63-linked isopeptide bond is not
involved in the interaction. In contrast, the specificity of
the interaction for Lys63-linked chains versus linear
chains is conformational as the Met1 residue of the
proximal ubiquitin is too far away from the C-terminus
of the distal ubiquitin in the diubiquitin complexes with
the NZF of TAB2 and TAB3.
Recognition of Lys63-linked diubiquitin
by a specific antibody
Interestingly, in an effort to reveal the role of poly-
ubiquitin chains of specific linkages in diverse biological
processes, antibodies were developed to recognize Lys63
versus Lys48 linkages [20]. The crystal structure of a Fab
fragment of a specific antibody in complex with Lys63-
linked diubiquitin revealed that the Fab interacts with
the diubiquitin at either side of the isopeptide linkage
with limited involvement of the Ile44 patch of either
ubiquitin (Figure 1I). It appears that the Fab specifically
recognizes a conformation of the diubiquitin that is
compatible with the Lys63, but not the Lys48, linkage.
Future directions
The recent structural studies may have pointed out a
number of rules or the lack of them in diubiquitin
recognition. First of all, diverse classes of UBDs are
capable of diubiquitin recognition and achieve the
specificity in their own manners. Second, the Ile44
hydrophobic patch is often crucial for diubiquitin
recognition, as is the case for monoubiquitin interaction,
and the spatial separation of UBDs in a protein may
facilitate the simultaneous interaction with the Ile44
patches in a diubiquitin. Third, the linkage residues
themselves may or may not be directly involved in UBD
interaction. Fourth, and importantly, intrinsic conforma-
tional preferences in solution of polyuibiquitin chains of
different linkages are important determinants in the
specificity of polyubiquitin chain recognition. Structural
studies of diubiquitins and tetraubiquitins have revealed
that Lys48-linked chains in general prefer a more
compact structure than either Lys63-linked chains or
linear chains [21-27]. It should be cautioned, however,
that crystal packing exerts significant influences in
polyubiquitin chain conformation [25,27]. Overall, it
appears that nature has developed a diverse repertoire of
interactions to provide specificity of polyubiquitin
recognition in biological processes.
Future structural studies on polyubiquitin chain interac-
tion may reveal recognition of UBDs with longer-chain
polyubiquitins. It is known that diubiquitin is often not
sufficient for eliciting the intended biological responses
such as in proteasomal targeting and NF-kB activation.
One reason for this requirement has been demonstrated
for simultaneous polyubiquitin chain recognitionby two
UBDs, which sets the chain length threshold [28].
Similarly, long polyubiquitin chains may serve as
extended scaffolds to mediate recruitment of multiple
copies of the signaling proteins to induce oligomeriza-
tion. Another reason for the requirement of longer chains
may be avidity, which increases the strength of the
interactions. Studies on long polyubiquitin chains may
be challenging but will certainly transform our current
thinking in polyubiquitin signaling.
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